Trial Details
TERMINATEDBasic Information
| Clinical ID | c2391 |
|---|---|
| Identifier | NCT03559517 |
| Trial Title | Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Ontamalimab|OTHER: Placebo |
Participant Information
| Sponsor | Shire |
|---|---|
| City | Tucson |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-08-29 |
|---|---|
| Primary Completion Date | 2020-07-07 |
| Completion Date | 2020-10-08 |